Lilly powers ahead with plant investment even as it cuts 3,500 jobs
admin 23rd October 2017 Uncategorised 0Even as pricing pressure on its diabetes portfolio has led Eli Lilly to cut 3,500 jobs by year-end, the drugmaker today said it is moving forward with a $72 million upgrade to its insulin manufacturing, part of an $850 million outlay it had expected to make this year on capital projects.
More: Lilly powers ahead with plant investment even as it cuts 3,500 jobs
Source: fierce